Paradigm claims that iPPS is a 1B market for OA and that the drug is "statistically significant" and DMOAD. However, there doesn't appear to be any interest in partnering for OA...how could that be?
AGM Meeting
-
- There are more pages in this discussion • 92 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
-0.005(1.72%) |
Mkt cap ! $99.69M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 28.5¢ | $34.79K | 121.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 70181 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 14.42pm 24/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |